Express Press Release Distribution

Accounting
Advertising
Aerospace
Agriculture
Apparel & Fashion
Automotive
Biotech
Chemicals
Computers
Construction
Consumer Services
Defense
Education
Electronics
Energy
Entertainment
Environment
Financial
Food & Beverage
Government
Healthcare
Human Resources
Industrial
International Trade
Internet & Online
Law
Management
Marketing
Media
Non Profit
Pharmaceuticals
Real Estate
Retail
Semiconductors
Small Business
Software
Sports
Telecommunications
Transportation / Logistics
Travel

EPR Archived News

Archived News 2012
~ April
~ March
~ February
~ January

Archived News 2011
~ December
~ November
~ October
~ September
~ August
~ July
~ June
~ May
~ April
~ March
~ February
~ January

Archived News 2010
Archived News 2009
Archived News 2008
Archived News 2007
Archived News 2006
Archived News 2005
Archived News 2004

 

AnaSpec Introduces New Line of Secretase Research Solutions

Released on = August 2, 2006, 4:53 pm

Press Release Author = Debra Thai

Industry = Biotech

Press Release Summary = As scientific research explores the role of b-Amyloid in
Alzheimer's Disease, the secretases whose cleavage activity produces b-Amyloid
fragments have become an important focus. One of the world's most comprehensive
providers of b-amyloid peptides, AnaSpec has introduced a new line of
amyloid-related secretase substrates, assay kits and inhibitors.

Press Release Body = Amyloid Precursor Protein, APP, a transmembrane glycoprotein of
about 770 amino acids, is cleaved by a-Secretase and b-Secretase to produce
C-terminal fragments that are 83 amino acids (C83) and 99-amino acids (C99) in
length, respectively. Subsequent cleavages of C83 and C99 by g-Secretase produce a
3-kD (p3) protein in the former and a 4-kD (b-amyloid) protein in the latter and a
CT57-59 in both fragments (reviewed in 1, 2). The 4-Kd consists of Ab which are 39
to 42 amino acids in length, with Ab 1-42 being the major component of amyloid
plaques which accumulates in neurons of Alzheimer's disease (AD) brain.
Consequently, b-Secretase is an important target for AD drug development.

FRET Secretase Substrates
AnaSpec provides fluorescence resonance energy transfer (FRET) substrates for use in
measuring b-Secretase activity. Upon cleavage of the FRET substrate by b-Secretase,
the quenched fluorescence of the donor is released, with the fluorescence signal
increasing with b-Secretase activity. Variations include a range of sequence
lengths and emission wavelengths.
· Wild-Type
· Swedish Double Mutation (K670N/M671L)

EnzoLyteT 520 ß-Secretase Assay Kit
· Ready-to-use assay kit for detection of b-Secretase V. 100 assays.

b -Secretase inhibitors
· High-purity peptides that inhibit b-Secretase activity.

a -Secretase Substrate
· A FRET-based a-Secretase substrate, which upon cleavage liberates the Mca
(7-Methoxycoumarin-4-acetic acid) fragment from the proximity quenching effect of
Dnp (2,4-dinitrophenyl), Abs/Em

Web Site = http://www.anaspec.com

Contact Details = 2149 O\'Toole Ave.
San Jose, CA 95131
408-452-5055
408-452-5059 fax
marketing@anaspec.com
info@anaspec.com
service@anaspec.com

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •